Delivery Order SPE2DB22D1017-SPE2DB25FF5GW
Award Date
2/11/25
Potential Completion Date
2/12/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,034.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,560,799,928 tablets of the antibiotic Linezolid 600 mg. The contract is a delivery order that runs through May 3, 2023, with a firm fixed price. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Linezolid 600 mg tablets, a medication used to treat certain bacterial infections. The award ceiling value is $1,545.26, and the contract is structured as a Firm Fixed Price Delivery Order with an ultimate completion date of February 3, 2025. This award is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,525.41 firm fixed-price delivery order is for the supply of LINEZOLID 600 MG TABLET 20S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Linezolid 600 mg tablets to support military healthcare programs. The $1,741.41 delivery order was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, as a child contract under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between the DLA and the parent company, Cencora, Inc. (doing business as Amerisourcebergen). This IDC serves as the primary...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,334.95 firm-fixed-price delivery order is for the supply of 150 ml bottles of the antibiotic medication Linezolid 100 mg/5 ml suspension. The contract has an ultimate completion date of January 17, 2025 and was awarded on January 16, 2025. The contract is not designated as a set-aside award. AmerisourceBergen Drug Corp holds a larger...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Linezolid 100 mg/5 ml suspension, a pharmaceutical product. The $1,711.91 firm-fixed-price delivery order contract has a completion date of June 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
The federal contract award SPE2DX15D1053|SPE2DX25F6HTC, with a ceiling value of $1,404, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of Linezolid 600 mg tablets. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,359.96 firm fixed-price delivery order is for the supply of Linezolid 100 mg/5 ml suspension, a pharmaceutical product used to treat infections. The contract has an ultimate completion date of January 12, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as...
This federal contract award is for the delivery of Linezolid 100 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award, valued at $7,730.46, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC...
This federal contract award, with ID SPE2DX15D1053|SPE2DX23F6VPX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp as the prime contractor. The contract is for the delivery of 150 ml bottles of the pharmaceutical drug Linezolid 100 mg/5 ml suspension, with a ceiling value of $8,698.66 and a period of performance through October 2, 2023. The contract is a firm-fixed-price Delivery Order, without a set-aside designation, indicating open...